The current study followed the long-term dynamics of semi-quantitative serum levels of IgA, IgM, IgG, and IgE against S-glycoprotein from patients presenting mild COVID-19 symptoms over 7 months after infection. The gene discussed is CD79A; the disease is COVID-19.